Mesothelioma patient reaches five years of survival following cutting edge treatment
Karen Grant did not expect to survive when she was diagnosed with mesothelioma five years ago at age 29. Mesothelioma is generally fatal, often within months of diagnosis. Enter Dr. David Sugarbaker, a surgeon at Brigham and Women’s Hospital in Boston, Massachusetts. He pioneered the surgeries that added years to Karen’s life. First, he cut out the tumors lining her lungs and lasered tiny cancer cells, then irrigated Karen’s chest cavity with heated chemotherapy. It was an aggressive approach that has paid off. Karen’s lung scans are clear today, and she couldn’t be happier. Five year mesothelioma survivors are pretty rare, and she’s looking forward to more healthy, active years.
Baron & Budd has been a support of Dr. Sugarbaker’s work, pledging $3 million over five years to the International Mesothelioma Program (IMP) at Brigham & Women’s Hospital. The IMP was founded by Dr. Sugarbaker to bring together a multidisciplinary team to pursue innovative research and effective treatment options for those suffering from mesothelioma.
For the full story, go to WCVB.
